CORONAVIRUS (COVID-19)-Plans for the next academic year. 

The teaching staff are now beginning to return to the School to resume their academic activities. They are working at a pace to change the way we deliver our courses. Moving forward, we will be using blended and e-learning methods. We aim to roll out the modules, which were postponed during the initial stages of COVID-19, in a phased approach, starting in September 2020, over an eight-month period. This is in line with Health Education England (HEE) who have proposed an extension to the education contract period. This is to allow time for the recovery of commissions that were postponed due to the pandemic.

As you will recognise because of COVID-19, plans are constantly changing so we will, as the situation evolves, endeavour to keep you informed. The health and wellbeing of our staff and students are our absolute priority. 

If you do have any questions or concerns, please refer to our Student Q&A page or contact us at Student Support Services for more information.

 

Cost

£997

Delivery method

Face to face

Length of module

5 days

Academic credits and level

15 credits at level 6 or 7

Course summary

The module will examine current research into the effectiveness of treatment and care of patients undergoing SACT including the pathophysiology of various approaches.  It will explore the legal, ethical, quality and safety issues inherent in their use.  Students will develop the skills to identify and manage the common side effects of different systemic anti-cancer therapies and the impact of treatment on patient’s physical, psychological and psychosocial wellbeing.

All theory will be linked to the outcomes from the UKONS SACT competency passport.

This module is in association with:

This course is currently unavailable.

Register your interest

If no dates are showing then please leave your details below and we will contact you when new dates are published. You can also contact school on 020 7808 2900 or school@rmh.nhs.uk